<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33692530</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-170X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Attributes and predictors of long COVID.</ArticleTitle><Pagination><StartPage>626</StartPage><EndPage>631</EndPage><MedlinePgn>626-631</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41591-021-01292-y</ELocationID><Abstract><AbstractText>Reports of long-lasting coronavirus disease 2019 (COVID-19) symptoms, the so-called 'long COVID', are rising but little is known about prevalence, risk factors or whether it is possible to predict a protracted course early in the disease. We analyzed data from 4,182 incident cases of COVID-19 in which individuals self-reported their symptoms prospectively in the COVID Symptom Study app<sup>1</sup>. A total of 558 (13.3%) participants reported symptoms lasting &#x2265;28&#x2009;days, 189 (4.5%) for &#x2265;8 weeks and 95 (2.3%) for &#x2265;12 weeks. Long COVID was characterized by symptoms of fatigue, headache, dyspnea and anosmia and was more likely with increasing age and body mass index and female sex. Experiencing more than five symptoms during the first week of illness was associated with long COVID (odds ratio&#x2009;=&#x2009;3.53 (2.76-4.50)). A simple model to distinguish between short COVID and long COVID at 7&#x2009;days (total sample size, n&#x2009;=&#x2009;2,149) showed an area under the curve of the receiver operating characteristic curve of 76%, with replication in an independent sample of 2,472 individuals who were positive for severe acute respiratory syndrome coronavirus 2. This model could be used to identify individuals at risk of long COVID for trials of prevention or treatment and to plan education and rehabilitation services.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sudre</LastName><ForeName>Carole H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Unit for Lifelong Health and Ageing, Department of Population Health Sciences, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-2413-923X</Identifier><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varsavsky</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graham</LastName><ForeName>Mark S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-4170-1095</Identifier><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penfold</LastName><ForeName>Rose S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowyer</LastName><ForeName>Ruth C</ForeName><Initials>RC</Initials><Identifier Source="ORCID">0000-0002-6941-8160</Identifier><AffiliationInfo><Affiliation>Zoe Global, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pujol</LastName><ForeName>Joan Capdevila</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0003-1658-1076</Identifier><AffiliationInfo><Affiliation>Zoe Global, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klaser</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonelli</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canas</LastName><ForeName>Liane S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molteni</LastName><ForeName>Erika</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7773-8140</Identifier><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Modat</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jorge Cardoso</LastName><ForeName>M</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1284-2558</Identifier><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>May</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Zoe Global, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganesh</LastName><ForeName>Sajaysurya</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3720-4176</Identifier><AffiliationInfo><Affiliation>Zoe Global, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Richard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2050-3994</Identifier><AffiliationInfo><Affiliation>Zoe Global, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Long H</ForeName><Initials>LH</Initials><Identifier Source="ORCID">0000-0002-5436-4219</Identifier><AffiliationInfo><Affiliation>Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drew</LastName><ForeName>David A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0002-8813-0816</Identifier><AffiliationInfo><Affiliation>Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astley</LastName><ForeName>Christina M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Division of Endocrinology &amp; Computational Epidemiology, Boston Children's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joshi</LastName><ForeName>Amit D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merino</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8312-1438</Identifier><AffiliationInfo><Affiliation>Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsereteli</LastName><ForeName>Neli</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Lund University Diabetes Centre, Department of Clinical Sciences, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fall</LastName><ForeName>Tove</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-2071-5866</Identifier><AffiliationInfo><Affiliation>Molecular Epidemiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez</LastName><ForeName>Maria F</ForeName><Initials>MF</Initials><Identifier Source="ORCID">0000-0001-6210-3142</Identifier><AffiliationInfo><Affiliation>Lund University Diabetes Centre, Department of Clinical Sciences, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duncan</LastName><ForeName>Emma L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menni</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9790-0571</Identifier><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Frances M K</ForeName><Initials>FMK</Initials><Identifier Source="ORCID">0000-0002-2998-2744</Identifier><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franks</LastName><ForeName>Paul W</ForeName><Initials>PW</Initials><Identifier Source="ORCID">0000-0002-0520-7604</Identifier><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lund University Diabetes Centre, Department of Clinical Sciences, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Andrew T</ForeName><Initials>AT</Initials><Identifier Source="ORCID">0000-0001-7284-6767</Identifier><AffiliationInfo><Affiliation>Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolf</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0530-2257</Identifier><AffiliationInfo><Affiliation>Zoe Global, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ourselin</LastName><ForeName>Sebastien</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5694-5340</Identifier><AffiliationInfo><Affiliation>School of Biomedical Engineering &amp; Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>AI Institute '3IA C&#xf4;te d'Azur', Universit&#xe9; C&#xf4;te d'Azur, Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Spector</LastName><ForeName>Tim</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-9795-0365</Identifier><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Steves</LastName><ForeName>Claire J</ForeName><Initials>CJ</Initials><Identifier Source="ORCID">0000-0002-4910-0489</Identifier><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, King's College London, London, UK. claire.j.steves@kcl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>203148</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>K23 DK120899</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AS-JF-17-011</GrantID><Acronym>ALZS_</Acronym><Agency>Alzheimer's Society</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nat Med. 2021 Jun;27(6):1116. doi: 10.1038/s41591-021-01361-2</RefSource><PMID Version="1">34045738</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>
<b>Competing interests</b>
. Zoe Global codeveloped the app pro bono for noncommercial purposes. Investigators received support from the Wellcome Trust, the MRC/BHF, European Union, French government, Alzheimer&#x2019;s Society, NIHR, CDRF and the NIHR-funded BioResource, Clinical Research Facility and BRC based at GSTT NHS Foundation Trust in partnership with KCL. R.D., J.W., J.C.P., A.M. and S.G. work for Zoe Global, and T.S. and P.W.F. are consultants to Zoe Global. L.H.N., D.A.D., J.M., P.W.F. and A.T.C. previously participated as investigators on a diet study unrelated to this work that was supported by Zoe Global. C.H.S., M.S.G., E.M., K.K., M.A., L.S.C., M.M., T.V., M.J.C. and S.O. declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33692530</ArticleId><ArticleId IdType="mid">EMS131037</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pii">10.1038/s41591-021-01292-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Menni C, et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020 doi: 10.1038/s41591-020-0916-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0916-2</ArticleId><ArticleId IdType="pmc">PMC7751267</ArticleId><ArticleId IdType="pubmed">32393804</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis and treatment of coronavirus disease 2019 (COVID-19): a review. J Am Med Assoc. 2020;324:782&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehy LM. Considerations for postacute rehabilitation for survivors of COVID-19. JMIR Public Health Surveill. 2020;6:e19462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7212817</ArticleId><ArticleId IdType="pubmed">32369030</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA. A negative COVID-19 test does not mean recovery. Nature. 2020;584:170.</Citation><ArticleIdList><ArticleId IdType="pubmed">32782377</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020;26:1037&#x2013;1040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7751267</ArticleId><ArticleId IdType="pubmed">32393804</ArticleId></ArticleIdList></Reference><Reference><Citation>Drew DA, et al. Rapid implementation of mobile technology for real-time epidemiology of COVID-19. Science. 2020 doi: 10.1126/science.abc0473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc0473</ArticleId><ArticleId IdType="pmc">PMC7200009</ArticleId><ArticleId IdType="pubmed">32371477</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, et al. Symptom clusters in COVID-19: a potential clinical prediction tool from the COVID Symptom study app. medRxiv. 2020 doi: 10.1101/2020.06.12.20129056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.12.20129056</ArticleId><ArticleId IdType="pmc">PMC7978420</ArticleId><ArticleId IdType="pubmed">33741586</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrani RD, Dabas N, Goldberger JJ. COVID-19 cardiac injury: implications for long-term surveillance and outcomes in survivors. Heart Rhythm. 2020 doi: 10.1016/j.hrthm.2020.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.06.026</ArticleId><ArticleId IdType="pmc">PMC7319645</ArticleId><ArticleId IdType="pubmed">32599178</ArticleId></ArticleIdList></Reference><Reference><Citation>Padda I, Khehra N, Jaferi U, Parmar MS. The neurological complexities and prognosis of COVID-19. SN Compr Clin Med. 2020 doi: 10.1007/s42399-020-00527-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00527-2</ArticleId><ArticleId IdType="pmc">PMC7522181</ArticleId><ArticleId IdType="pubmed">33015552</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health Research. Living with COVID-19. 2020 doi: 10.3310/themedreview_41169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/themedreview_41169</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson LB, et al. COVID-19 severity in hospitalized patients with asthma: a matched cohort study. J Allergy Clin Immunol Pract. 2021;9:497&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7580590</ArticleId><ArticleId IdType="pubmed">33164794</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute COVID-19 in primary care. Br Med J. 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiel C, et al. A Euclidean distance-based matching procedure for nonrandomized comparison studies. Eur Psychol. 2008;13:180&#x2013;187.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>